Average Co-Inventor Count = 4.22
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (11 from 4,455 patents)
2. Pharmacia & Upjohn Company (6 from 523 patents)
3. Cystic Fibrosis Foundation Therapeutics, Inc. (3 from 5 patents)
4. Cystic Fibrosis Foundation (3 from 3 patents)
5. Cellarity, Inc. (2 from 3 patents)
6. Ensemble Therapeutics Corporation (1 from 5 patents)
26 patents:
1. 12473285 - DCN-1 modulating compounds and methods of use thereof
2. 12435087 - Modulators of DCN-1 and methods of use thereof
3. 12312344 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
4. 12077533 - Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
5. 11708360 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
6. 11111242 - Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
7. 10975065 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
8. 10766904 - Bicyclic heteroaryl derivatives as CFTR potentiators
9. 10703756 - Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereof
10. 10494374 - Pyrrolopyrimidines as CFTR potentiators
11. 10377762 - Bicyclic heteroaryl derivatives as CFTR potentiators
12. 10301315 - Pyrrolopyrimidines as CFTR potentiators
13. 10208053 - Bicyclic heteroaryl derivatives as CFTR potentiators
14. 10131670 - Bicyclic heteroaryl derivatives as CFTR potentiators
15. 9617258 - Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides